Sign up


Match Document Document Title
7666844 Dry mouldable drug formulation  
Solid pharmaceutical compositions for parenteral injection comprising a binder and at least one therapeutic agent. The pharmaceutical composition has the strength to be injected directly with the...
7662801 Biodegradable oxidized cellulose esters  
The present invention relates to the preparation of a series of oxidized cellulose esters suitable for use as a drug carrier in the development of biodegradable controlled and/or sustained release...
7662800 Hyaluronic acid derivatives  
Derivatives between hyaluronic acid and at least one nitrogenated base, in particular at least one heterocyclic compound derived from purine and/or from pyrimidine and cosmetic and/or...
7658952 Dialysis solutions containing pyrophosphates  
Dialysis solutions comprising pyrophosphates and methods of making and using the dialysis solutions are provided. In an embodiment, the present disclosure provides a dialysis solution comprising a...
7659259 Method of treating inflammation of the eye  
The present invention includes a method of treating inflammation of the eye comprising administering to an eye of a patient suffering from inflammation of the eye, a composition comprising an...
7655639 Minimally invasive clinical treatment method for closure of umbilical hernias  
The present invention is a minimally invasive clinical method for closing hernias and other abnormal openings existing within the body; and is a unique alternative to conventional surgery and...
7651703 Injection vehicle for polymer-based formulations  
The invention provides injection vehicles suitable for administering particulate suspensions, such as polymer-based formulations, as well as associated pharmaceutical formulations, articles of...
7648968 Methods of treating dermal ulcers using glucans  
The present invention is directed to methods of using glucan compositions, comprising water insoluble microparticulate glucans, in the treatment of dermal ulcers. The water insoluble...
7645803 Saccharide foamable compositions  
A foamable composition, containing a saccharide for use in the treatment of various disorders including: water, a saccharide, about 0.2% to about 5% by weight of a surface-active agent, about 0.01%...
7645742 Composition for enhancing cellular energy  
A composition for enhancing cellular energy that includes creatine, L-arginine-α-ketoglutarate, D-ribose, L-carnitine, L-citrulline, and pyruvate. The composition is administering to a subject to ...
7641914 Acid-sensitive compounds, their preparation and uses  
Novel acid-sensitive compounds comprising a cyclic ortho-ester that is acid-sensitive, and their salts, and comprising at least one hydrophilic substituent. These compounds are useful, for example,...
7638503 Small molecule stimulators of neuronal growth  
Provided herein are small molecule stimulators of neuronal growth, their preparation, and their use for treatment of neurological disorders. In one embodiment, provided herein are methods of...
7638504 Hepatitis a viricide  
The invention relates to agents which combat the hepatitis A virus, containing only minimal amounts of chlorine-containing and/or chlorine cleaving active ingredients, or none of said substances....
7629331 Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof  
A particulate SAE-CD composition is provided. The SAE-CD composition has an advantageous combination of physical properties not found in known solid forms of SAECD. In particular, the SAE-CD...
7629330 Use of zwitterionic polysaccharides for the specific modulation of immune processes  
The invention relates to three-dimensional molecular structure determination of polymers, three-dimensional computer molecular modeling, rational drug design, and immunomodulatory polymers. In...
7629313 Immunomodulatory polymeric antigens for treating inflammatory pathologies  
Provided are natural and synthetic immunomodulatory polymeric antigens (SPAs), compositions containing SPAs, and methods of using these natural and synthetic SPAs and compositions to prevent or...
7625581 Tissue scaffolds for use in muscoloskeletal repairs  
The present invention includes a tissue scaffold suitable for use in repair and/or regeneration of musculoskeletal tissue when implanted in a body that includes a porous substrate made from a...
7622459 Method of preparation of a fungal glucane hydrogel having antibacterial and immunostimulant activity, and use thereof  
A method of preparation of a fungal glucane hydrogel having antibacterial and immunostimulant activity by alkaline deproteination and subsequent elimination of water-soluble components consists in...
7618951 Use of prebiotics, preferably glucooligosaccharide, for the prevention of the onset of type II diabetes  
The invention relates to the use of prebiotics for the preparation of food or pharmaceutical compositions which are intended for the treatment and/or prevention of hyperglycaemic syndromes and, in...
7612029 Controlled release using gels in a melamine foam  
A substrate comprising a nonwoven layer containing an ionically crosslinked polymer can be used to control the release of active ingredients. The substrate can be a melamine foam and contain a...
7608436 Process for producing saccharide oligomers  
A process for preparing saccharide oligomers uses an aqueous feed composition that comprises at least one monosaccharide or linear saccharide oligomer, and has a solids concentration of at least...
7601704 Process for synthesizing oil and surfactant-free hyaluronic acid nanoparticles and microparticles  
A method for synthesizing uniformly sized hyaluronic acid (“HA”) particles that are substantially free from oil and surfactant contaminants. The method comprises crosslinking HA chains with 1-e...
7601364 Carbohydrate mixtures  
A carbohydrate mixture for dietetic foods and pharmaceuticals containing several carbohydrates is provided. The carbohydrate mixture comprises two different, substantially soluble carbohydrate...
7595307 Polysaccharide derivatives and uses in induction of an immune response  
The present invention generally provides compositions comprising a polysaccharide derivative, and methods of their preparation and use for the prevention or treatment of diseases caused by...
7592327 Asthma/allergy therapy that targets T-lymphocytes and/or eosinophils  
A pharmaceutical composition for the treatment and/or prophylaxis of diseases caused by type I hypersensitivity reactions consisting essentially of Glicophosphopeptical, or pure Nigella Sativa...
7589080 β-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases  
Methods of reducing the risk of transmission of a sexually transmitted pathogen by contacting the pathogen or cells susceptible to infection by the pathogen with a β-cyclodextrin are provided. ...
7589051 Cationic, oxidized polysaccharides in conditioning applications  
A cationic, oxidized polysaccharide or derivative thereof that has a mean average molecular weight (Mw) having a lower limit of 50,000 and an upper limit of 1,000,000 and an aldehyde functionality...
7582620 Use of mannan from saccharomyces cerevisiae for the treatment of asthma  
The present invention provides methods of using mannose receptor blocker to treat airway disease such as asthma. The present invention also provides methods for reducing smooth muscle mass in an...
7579017 Physical mode of action pesticide  
A physical mode of action pesticide for application on plants and in soils, and methods of manufacture and application, comprising an active ingredient in the form of a polymer in a concentration...
7576070 Method for producing pectin hydrolysis products  
The present invention relates to methods for the production of pectin hydrolysis products, the pectin hydrolysis products produced in this manner, as well as their use.
7576071 Antithrombotic compound  
The present invention relates compounds of the formula A oligosaccharide-spacer-GpIIb/IIIa antagonist (A). The compounds of the invention have antithrombotic activity and can be used in treating or...
7575755 Immunogenic compositions and uses thereof  
The present invention relates generally to a method of eliciting or otherwise inducing an effective immune response to a micro-organism and compositions for use therein. More particularly, the...
7569557 Compositions of estrogen-cyclodextrin complexes  
Pharmaceutical compositions comprising low doses of sensitive complexes between an estrogen and a cyclodextrin are provided with improved stability. In specific embodiments the composition...
7566704 Very high molecular weight β-glucans  
The invention pertains to compositions and therapeutic and prophylatic methods for treating/preventing infections in an animal or human by administering a soluble β-glucan composition comprising ...
7560443 Mixtures of fructose, sucrose and lactose as a low-calorie bulk sweetener with reduced glycemic index  
Mixtures of fructose and lactose are useful for reducing caloric intake and glycemic index for individuals who are overweight, glucose-impaired, diabetic, or who just consume too large a fraction...
7553479 Heat stable colloidal iron oxides coated with reduced carbohydrates and uses thereof  
Compositions, methods of making the compositions, and methods of using the compositions are provided for an enhanced magnetic resonance imaging agent and a hematinic agent, the agents comprising...
7553482 Use of a phosphate adsorbent to combat vascular diseases  
The invention relates to the use of an adsorption material which has been modified with polynuclear metal oxide hydroxides for influencing the calcium level and, in particular, for treating or/and...
7553824 Kit for determining polysaccharide-binding activity of mononuclear cells present in peripheral blood  
A kit for the determination of the ability of a peripheral blood mononuclear cell to bind to a polysaccharide herein provided comprises a detection reagent comprising a fluorescence-labeled...
7544671 Stabilized hyaluronan preparations and related methods  
Stabilized hyaluronan preparations wherein hyaluronan is combined with a polyglycol, such as polyethylene glycol. Stabilized hyaluronan preparations of this invention may maintain their viscosity...
7538096 Treatment and prevention of abnormal cellular proliferation  
This invention provides a method for inhibiting or preventing the abnormal growth of cells, including transformed cells, by administering an effective amount of O-acylated heparin derivative....
7524514 Biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan  
The present invention relates to a three dimensional, malleable cell culture composition and method of forming the same comprising hyaluronic acid, chitosan and a polyelectrolytic complex of...
7521433 Gene carriers with the use of polysaccharide and process for producing the same  
Disclosed are gene carriers utilizing β-1,3-glucan and methods of preparing the same. The β-1,3-glucan has at least one 1,6-glucopyranoside branch and is chemically modified through periodate o...
7521434 Cross-linked gels of hyaluronic acid with hydrophobic polymers and processes for making them  
The present invention provides for compositions of hyaluronic acid cross-linked with at least one other hydrophobic polymer to form a copolymer gel. The preferred composition is a formulation...
7514097 Use of soluble cellulose derivative having been made hardly soluble in water and process for producing the same  
(1) A tissue-covering medical material which comprises a soluble cellulose derivative having been made hardly soluble in water, which is used with a purpose of being embedded in the body or applied...
7511026 Therapeutic agent for nerve damage  
The present invention provides a therapeutic agent for nerve damages such as those caused by spinal cord injury or nerve trauma, which includes, as an active ingredient, a low-molecular-weight...
7511095 Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith  
The invention provides reagents and methods for conjugating a polymer specifically to the α-amine of a polypeptide. The invention provides monofunctional, bifunctional, and multifunctional PEGs ...
7507723 Hyaluronic acid oligosaccharide fractions and drugs containing the same  
Hyaluronic acid oligosaccharides having a size selected from sizes of 4 to 60 saccharides, fractions containing the hyaluronic acid oligosaccharides and having particular physicochemical...
7504384 Use of lipid conjugates in the treatment of infection  
This invention provides compounds and methods of use thereof in suppressing, inhibiting, preventing, or treating a pathogenic effect on a cell, including, inter alia, infection with intracellular...
7504386 Biomaterials for preventing post-surgical adhesions comprised of hyaluronic acid derivatives  
New biomaterials essentially constituted by esterified derivatives of hyaluronic acid or by cross-linked derivatives of hyaluronic acid for use in the surgical sector, particularly for use in the...
7504387 Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis  
The invention provides compositions and methods useful for the treatment and/or prevention of interstitial cystitis and/or a related urinary tract condition in man or in animals. Specifically,...